Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 2
2011 3
2012 7
2013 1
2014 3
2015 4
2016 7
2017 7
2018 4
2019 5
2020 13
2021 15
2022 10
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Griffith DE, et al. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC. Am J Respir Crit Care Med. 2018. PMID: 30216086 Clinical Trial.
Tuberculoma.
Tanizaki R, Takasaki J. Tanizaki R, et al. Among authors: takasaki j. Intern Med. 2014;53(13):1457-8. doi: 10.2169/internalmedicine.53.2354. Epub 2014 Jun 15. Intern Med. 2014. PMID: 24990343 Free article. No abstract available.
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, Ince D, Takasaki J, Sweeney DA, Sandkovsky U, Wyles DL, Hohmann E, Grimes KA, Grossberg R, Laguio-Vila M, Lambert AA, Lopez de Castilla D, Kim E, Larson L, Wan CR, Traenkner JJ, Ponce PO, Patterson JE, Goepfert PA, Sofarelli TA, Mocherla S, Ko ER, Ponce de Leon A, Doernberg SB, Atmar RL, Maves RC, Dangond F, Ferreira J, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd L, Tomashek KM, Beigel JH; ACTT-3 study group members. Kalil AC, et al. Among authors: takasaki j. Lancet Respir Med. 2021 Dec;9(12):1365-1376. doi: 10.1016/S2213-2600(21)00384-2. Epub 2021 Oct 18. Lancet Respir Med. 2021. PMID: 34672949 Free PMC article. Clinical Trial.
Suspected Tuberculous Pleurisy and Coronavirus Disease 2019 Comorbidity.
Yamaguchi Y, Hashimoto M, Saito S, Morita T, Tsukada A, Kusaba Y, Katsuno T, Suzuki M, Takasaki J, Izumi S, Matsunaga A, Ishizaka Y, Hojo M, Sugiyama H. Yamaguchi Y, et al. Among authors: takasaki j. Intern Med. 2022 Mar 15;61(6):913-916. doi: 10.2169/internalmedicine.6920-21. Epub 2021 Dec 28. Intern Med. 2022. PMID: 34980790 Free PMC article.
Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.
Uchihara M, Bouchi R, Kodani N, Saito S, Miyazato Y, Umamoto K, Sugimoto H, Kobayashi M, Hikida S, Akiyama Y, Ihana-Sugiyama N, Ohsugi M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H. Uchihara M, et al. Among authors: takasaki j. J Diabetes Investig. 2022 Jun;13(6):1086-1093. doi: 10.1111/jdi.13754. Epub 2022 Feb 7. J Diabetes Investig. 2022. PMID: 35075818 Free PMC article.
Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial.
Terada-Hirashima J, Suzuki M, Tsujimoto Y, Hamamoto Y, Uemura Y, Tsushima K, Inoue H, Komatsu S, Saito Z, Tsuzuki R, Okamoto M, To Y, Moriya K, Yoshizawa S, Tanaka M, Muto T, Mikami A, Takasaki J, Izumi S, Ohmagari N, Hojo M, Sugiura W, Sugiyama H. Terada-Hirashima J, et al. Among authors: takasaki j. Drug Discov Ther. 2022 Nov 20;16(5):225-232. doi: 10.5582/ddt.2022.01068. Epub 2022 Oct 26. Drug Discov Ther. 2022. PMID: 36288939 Free article. Clinical Trial.
Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19.
Uchihara M, Kodani N, Bouchi R, Saito S, Miyazato Y, Sugimoto H, Umamoto K, Kobayashi M, Ihana-Sugiyama N, Ohsugi M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H. Uchihara M, et al. Among authors: takasaki j. Glob Health Med. 2022 Dec 31;4(6):336-340. doi: 10.35772/ghm.2022.01053. Glob Health Med. 2022. PMID: 36589220 Free PMC article.
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y, Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama H. Katagiri D, et al. Among authors: takasaki j. J Clin Apher. 2021 Jun;36(3):313-321. doi: 10.1002/jca.21861. Epub 2020 Dec 15. J Clin Apher. 2021. PMID: 33325084 Free PMC article.
Evaluation of the Detection of Pathogens in Hospitalized Patients with COVID-19 at a Tertiary Hospital in Japan.
Suzuki M, Hayakawa K, Asai Y, Matsunaga N, Terada M, Ohtsu H, Toyoda A, Takasaki J, Hojo M, Yanagawa Y, Saito S, Yamamoto K, Ide S, Akiyama Y, Suzuki T, Moriya A, Mezaki K, Ohmagari N. Suzuki M, et al. Among authors: takasaki j. Jpn J Infect Dis. 2022 Jul 22;75(4):419-422. doi: 10.7883/yoken.JJID.2021.232. Epub 2022 Feb 28. Jpn J Infect Dis. 2022. PMID: 35228500 Free article.
76 results